Showing results (621-630 of 781) with videos related to
Sort By:
Pageof 79
Heliyon|December 27, 2023
Social enrichment alters the response of brain leukocytes to chemotherapy and tumor development in aged miceWilliam H Walker Ii, Jennifer A Liu, O Hecmarie Meléndez-Fernández, et al.Obesity (Silver Spring, Md.)|August 8, 2023
Myogenically differentiated mesenchymal stem cell insulin sensitivity is associated with infant adiposity at 1 and 6 months of ageFilip Jevtovic, Donghai Zheng, Joseph A Houmard, et al.Journal of Neuro-Oncology|November 22, 2021
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapyMehran Yusuf, Abbas Rattani, Jeremy Gaskins, et al.Aging|August 19, 2021
Stress-induced aberrations in sensory processing predict worse cognitive outcomes in healthy aging adultsRachel K Spooner, Brittany K Taylor, Emma L'Heureux, et al.Oral Oncology|January 9, 2019
Prognostic factors and selection criteria in the retreatment of head and neck cancersMichael E May, Elizabeth D Cash, Craig L Silverman, et al.Circulation Research|August 29, 2012
The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signalingOliver Borst, Patrick Münzer, Sergios Gatidis, et al.The Journal of Pathology|May 1, 1990
NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissueI P Corbett, J A Henry, B Angus, et al.European Heart Journal|May 27, 2008
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapyTobias Geisler, Christine Zürn, Maria Paterok, et al.Journal of the American Chemical Society|October 4, 2012
Molecular insights into the biosynthesis of guadinomine: a type III secretion system inhibitorTracy C Holmes, Aaron E May, Kathia Zaleta-Rivera, et al.SLAS Discovery : Advancing Life Sciences R & D|March 2, 2023
Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistryGlen E Kellogg, Yana Cen, Malgorzata Dukat, et al.Pageof 79